Pharmaceutical firms pile up cash reserves

Published: 2012-08-22 06:59:00

Updated: 2012-08-22 06:59:00

Korean drug companies piled up cash reserves in the first half of this year, as they refrained from investing amid the market downturn stemming from the impact of the drug price cuts in April.

According to a report released by Yakup.com, a pharmaceutical information provider, Cashable assets o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK